INTRODUCTION
============

The discovery of *Helicobacter pylori* (HP) and the analysis of its correlation with inflammatory changes of the digestive mucosa has been the subject of numerous studies. Many points correlate this bacterium and wide range of gastroduodenal diseases by modifying the understanding of the pathophysiology and creating open questions whether its treatment can prevent complications.

It is known that the acquisition of this infection has interpersonal transmission, is related to socioeconomic and environmental factors, being more prevalent in developing countries[@B4] ^,^ [@B18] ^,^ [@B26].

HP is gram-negative spiral bacillus, flagellate, usually not invasive, remaining on the surface of the gastric mucosa. Small proportion of the bacterial cells adheres to mucosal epithelium. Its spiral shape and flagella make it mobile on the mucosal environment and its effective urease protects against acid, catalyzing urea hydrolysis to produce ammonia buffer[@B7].

HP infection is related to the development of lesions and gastric lymphomas; however, it is not known for sure if there is a correlation with gastroesophageal reflux and reflux esophagitis[@B3] ^,^ [@B20]. The literature already described its association with duodenitis[@B6] ^-^ [@B8] and functional dyspepsia[@B5] ^,^ [@B8] ^-^ [@B13].

Establish properly the relationship with the various gastroduodenal diseases is challenging, because the presence of infection has an influence in the same patient positively in some aspects and negative in others.

The aim of this study was to correlate the inflammatory endoscopic findings in positive and negative HP groups in order to examine whether there is a relationship with the onset of major mucosal diseases of the upper digestive tract.

METHODS
=======

It is a comparative observational study. Data were collected from 2247 patients undergoing endoscopy and biopsies for HP with urease test attended by the Endoscopy Service, Hospital 9 of July, São Paulo, SP, Brazil.

Inclusion criteria were patients over 18 years of both genders who underwent endoscopy with rapid urease test, regardless of the examination reason request, ongoing disease or drug use. Exclusion criteria were: active bleeding during the examination; use of anticoagulants; without HP result by urease; HIV positive; with previous operations; tumors in the esophagus, stomach and duodenum; and when full and detailed examination was not possible (resistant to sedation, hypoxia or arrhythmia during the examination).

Based on 2247 patients was formed two groups: HP+ 16.6% and HP- with 83.4%. Within them, were searched endoscopic findings for the following alterations: esophagitis according to the Los Angeles classification, esophageal ulcer, non-erosive gastritis according to the Sydney classification, erosive gastritis, gastric ulcer, bulboduodenitis, bulbar ulcer and without disease. To identify ulcers, was used the definition of Paris classification.

For the urease and/or histological exams, biopsies were performed on body and antrum with biopsy forceps, and the material was placed in prefabricated reagent for the urease test.

The patients were previously submitted to the usual preparation for endoscopy - fasting for 8 h for solids and liquids. Immediately before the test were asked to ingest 10 ml of water with 40 drops of simethicone and, also, submitted to 5-10 puffs of lidocaine spray in the oropharynx.

Statistical analysis

For the analysis of the data was used the statistical software SPSS 23.0. Patients whose urease test was negative (HP-) served as control group for those who test was positive (HP+) in order that it could compare the HP presence influenced positively or negatively the studied conditions. To determine whether the samples had statistically significant results, was used the Pearson chi-square with an accuracy of 5% or p\<0.5, in order to avoid results that could have been generated at random.

RESULTS
=======

Comparative analysis of mucosal changes
---------------------------------------

### Esophagitis in HP+ and HP- groups

Comparing the incidence of esophagitis between HP+ group (67.11%) with the HP- control group (69.89%) there was little disparity in the distribution favorable to HP+ group that had slightly lower percentile of this disease. However, the data analysis about this disproportion was not statistically significant (p=0.287464, \>.05, [Table 1](#t1){ref-type="table"}A)

TABLE 1Incidence of esophagitis (A) and esophageal ulcer (B) in the HP+ and HP- groupsAesophagitis yes%esophagitis no%total%Hpylori positive25167,1112332,89374100,00Hpilory negative130969,8956430,111873100,00total156069,4368730,572247100,00Besopha ul yes%esopha ul no%total%Hpylori positive00,00374100374100,00Hpilory negative40,21186999,791873100,00total40,18224399,822247100,00

### Esophageal ulcer in HP+ and HP- groups

Comparing the incidence of esophageal ulcer in HP+ group (0%) with the HP- (0.21%) was observed low incidence in both groups, with small disproportion in favor distribution to HP+ group that showed no cases of this disease. However, analysis of the disproportion was not statistically significant (p=0.371051, \>.05, [Table 1](#t1){ref-type="table"}B).

### Gastritis in HP+ and HP- groups

Comparing the incidence of gastritis in HP+ group (78.34%) with the HP- control group (73.63%) there was a certain disproportion in the distribution, in favor of HP-group that had lower percentile. However, the data analysis of this disproportion was not statistically significant (p=0.56, \>.05, [Table 2](#t2){ref-type="table"}).

TABLE 2Gastritis incidence on HP+ and HP- groupsgastritis yes%gastritis no%total%Hpylori positive29378,348121,66374100,00Hpilory negative137973,6349426,371873100,00total167274,4157525,592247100,00

### Erosive gastritis in HP+ and HP- groups

Comparing the incidence of erosive gastritis in HP+ group (67.11%) and HP- (64.55%) there was little distribution disproportion in favor to the HP- group showing slightly lower percentile. However, the data analysis of this disproportion was not statistically significant (p=0.343, \>.05, [Table 3](#t3){ref-type="table"}).

TABLE 3Effect of erosive gastritis in HP+ and HP- groupseros gast yes%eros gast no%total%Hpylori positive25167,1112332,89374100,00Hpilory negative120964,5566435,451873100,00total146064,9878735,022247100,00

### Bulboduodenitis in HP+ and HP- groups

Comparing the incidence of bulboduodenitis in HP+ and HP- groups (1.23%) was observed small disproportion in favor distribution to HP that showed slightly lower percentile group. However, the data analysis of this disproportion was not statistically significant (p=0.322, \>.05, [Table 4](#t4){ref-type="table"}).

TABLE 4Bulboduodenitis incidence on HP+ and HP- groupsbulboduo yes%bulboduo no%total%Hpylori positive71,8736798,13374100,00Hpilory negative231,23185098,771873100,00total301,34221798,662247100,00

### Gastric ulcer in HP+ and HP- groups

Comparing the incidence of gastric ulcer in HP+ group (2.14%) and HP- (2.03%) there was little disparity in the distribution, in favor to HP- group showing slightly lower percentile. However, the data analysis of this disproportion was not statistically significant (p=0.523, \>.05, [Table 5](#t5){ref-type="table"}).

TABLE 5Incidence of gastric ulcer in HP+ and HP- groupsgastr ul yes%gastr ul no%total%Hpylori positive82,1436697,86374100,00Hpilory negative382,03183597,971873100,00total462,05220197,952247100,00

### Bulbar ulcer in HP+ and HP- groups

Comparing the incidence of bulbar ulcer in HP+ group (10.16%) with the HP-control group (4.48%) was observed inequalities in the distribution, in favor of HP-group that had lower percentile. Furthermore, the analysis of data from this disproportion was highly statistically significant (p=0.00001, \<.05, [Table 6](#t6){ref-type="table"}A).

TABLE 6Incidence of bulbar ulcer (A) and absence of lesions (B) on HP+ and HP- groupsAbulbar ul yes%bulbar ul no%total%Hpylori positive3810,1633689,84374100,00Hpilory negative844,48178995,521873100,00total1225,46212594,572247100,00Bno alter yes%no alter no%total%Hpylori positive184,8135695,19374100,00Hpilory negative1186,30175593,701873100,00total1366,05211193,952247100,00

### Absence of alterations in the HP+ and HP- groups

Comparing the incidence of the absence of changes in HP+ group (4.81%) with the HP- control group (6.30%) there was a certain distribution disproportion in favor to the HP- group that presented percentile a little larger than absence of disease. However, the data analysis of this disproportion was not statistically significant (p=0.2708, \>.05, [Table 6](#t6){ref-type="table"}B).

DISCUSSION
==========

Colonization by HP mucosa predisposes to peptic ulcer disease, gastric atrophy and subsequent gastric cancer due to various changes in gastric acid secretion.

In this study the most common diseases for patients with PH+ were gastritis (78.34%), esophagitis (67.11%) and erosive gastritis (67.11%). Other diseases have very low prevalence and were bulbar ulcer (10.16%), gastric ulcer (2.14%), bulboduodenitis (1.87%) and esophageal ulcer (0.00%), with similar results already presented[@B3] ^,^ [@B5] ^,^ [@B17] ^,^ [@B23].

Although the bacteria was initially implicated in the pathogenesis of gastroesophageal reflux and esophagitis, several studies have shown that its prevalence is smaller than the rest of population[@B19] ^,^ [@B22] ^,^ [@B25] ^,^ [@B28]. It is explained by gastric atrophy and subsequent reduction of gastric acid secretion, which would lead to lower esophageal injury. Nevertheless, due to its involvement in gastric carcinogenesis is recommended its erradication[@B15] ^,^ [@B19].

It was not analyzed here the carcinogenic effects, direct or indirect, nor gastric atrophy or gastroesophageal reflux associated with infection by HP. It was possible to analyze data related to ulcers in the digestive tract, where it was confirmed a direct relationship between the presence of ulcers and HP+; but only to bulbar ulcers this ratio proved to be significant. With no correlation with the literature, was observed the inverse relationship between HP and esophageal ulcer, but with very small and statistically insignificant disproportion.

The data also demonstrated an inverse relationship between the presence of HP and esophagitis, with smaller percentage for HP+ group compared to HP-. The numbers of this relationship did not reach statistical significance, but confirmed the cited literature.

The HP infection is considered the main cause of chronic gastritis[@B1] ^,^ [@B9] and studies suggest that this agent plays an important role in the genesis of peptic ulcer[@B19]. After finding that its eradication entails the healing of the ulcer, it was decided that patients with HP should receive specific treatment. The eradication of bacteria restores the gastric mucosa and end the carcinogenic development of acute gastritis (chronic gastritis - atrophy - metaplasia - dysplasia - cancer). Muller et. al.[@B12] found that patients with HP+ showed odds ratio 10 times higher (95% CI=6.50% -17%) to present some degrees of gastric mucosal injury than those with absence. It is estimated that only portion of infected individuals develop HP gastroduodenal diseases due to different pathogenic strains. Studies have shown that infection with HP- Cag A+ is associated with alterations in cell cycle and apoptosis in gastric epithelial and more pronounced levels of inflamation[@B11] ^,^ [@B14]. The HP Cag A+ is also associated with higher intensity of atrophy and intestinal metaplasia[@B10] ^,^ [@B16] ^,^ [@B21] ^,^ [@B24].

Studies have also shown a strong relationship between duodenal ulcer and HP[@B26] ^,^ [@B27]. They found duodenal ulcer as the most common injury in their papers. Caetano et. al.[@B2] studied 150 patients prospectively evaluating, from the total of 1,043 cases, chronic gastritis that was found in 109 patients (72.6%), gastric ulcer in six (4%), nine chronic duodenitis (6%) and 26 duodenal ulcers (17.4%). Then, they grouped patients in which 103 (68.67%) had positive urease test, 104 (69.33%) histologically positive and 98 (65.33%) seropositivity for HP. Marques[@B12], analyzing 1478 presented the most frequent endoscopic findings: gastritis (n=810, 54.8%); gastric and duodenal peptic ulcers (n=494, 33.4%); duodenitis (n=287, 19.4%) and esophagitis (n=217, 14.7%); prevalence of HP infection in 53% (n=786) increasing the risk of gastric and duodenal ulcers in 1.9 and 1.6 times.

The data presented here had much lower percentage than reported in the literature (16.6%). However, they denote certain propensity, although small and insignificant, of the HP+ individuals to present changes in mucosal group, and on a global analysis, only 6.30% of HP+ group did not show any kind of change against 4.81% the HP- (control) group. It must be emphasized, again, that for specific relationship between HP and ulcer bulbar the numbers were significant.

CONCLUSION
==========

There is no differentiation between HP- and HP+ groups in endoscopic inflammatory changes in the gastroduodenal mucosa, except for the relationship between HP and bulbar ulcer.
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